Phase III ATENA Trial of Exemestane Discontinued

Author： Sweetlove Mel  

Publisher： Adis International

ISSN： 1178-2595

Source： Pharmaceutical Medicine, Vol.26, Iss.1, 2012-02, pp. : 45-47

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase III Trial of Eprotirome: Discontinued for Safety Concerns

By Sweetlove Mel  

Pharmaceutical Medicine, Vol. 26, Iss. 3, 2012-06 ,pp. : 185-187

Adis International

Access to resources Recommend Favorite

Phase III Trial of Dalcetrapib: Discontinued Due to Lack of Efficacy

By Sweetlove Mel  

Pharmaceutical Medicine, Vol. 26, Iss. 4, 2012-08 ,pp. : 253-256

Adis International

Access to resources Recommend Favorite

Phase III Trial of Lapatinib: Discontinued due to Inferior Efficacy

By  

Pharmaceutical Medicine, Vol. 26, Iss. 5, 2012-10 ,pp. : 321-325

Adis International

Access to resources Recommend Favorite

GlaxoSmithKline (GSK) has discontinued enrolment into its phase III trial of the HIV entry inhibitor, aplaviroc [GW 873140]

By  

Reactions Weekly, Vol. 1, Iss. 1076, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Phase III CONCERT Trial of Latrepirdine: Negative Results

By Sweetlove Mel  

Pharmaceutical Medicine, Vol. 26, Iss. 2, 2012-04 ,pp. : 113-115

Adis International

Access to resources Recommend Favorite